Alkermes (STU:8AK) ROE % Adjusted to Book Value : 3.31% (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Alkermes ROE % Adjusted to Book Value?

Alkermes's ROE % for the quarter that ended in Mar. 2024 was 12.01%. Alkermes's PB Ratio for the quarter that ended in Mar. 2024 was 3.63. Alkermes's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was 3.31%.

Alkermes ROE % Adjusted to Book Value Historical Data

The historical data trend for Alkermes's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alkermes ROE % Adjusted to Book Value Chart

Alkermes Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-6.46

-3.47

-1.43

-4.05

8.25

Alkermes Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-3.84	22.07	4.51	9.20	3.31

Competitive Comparison of Alkermes's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Alkermes's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alkermes's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alkermes's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Alkermes's ROE % Adjusted to Book Value falls into.

Alkermes ROE % Adjusted to Book Value Calculation

Alkermes's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	31.25%	/	3.79
	=	8.25%

Alkermes's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	12.01%	/	3.63
	=	3.31%

Alkermes ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Alkermes's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Alkermes (STU:8AK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alkermes PLC (STU:8AK) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

ALKS:USA 8AK:Germany

Address

1 Burlington Road, Connaught House, Dublin, IRL, D04 C5Y6

Website

https://www.alkermes.com

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several collaborative arrangements to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies.

Alkermes (STU:8AK) Headlines

No Headlines